Nausea in Early Pregnancy: Onset, Peak, Resolution, and Management

Nausea and vomiting of pregnancy (NVP), misnamed “morning sickness,” affects 70–80% of pregnancies. It is a positive prognostic sign (lower miscarriage risk) but can be debilitating.

Typical Timeline

  • Onset: 4–6 weeks gestation (LMP); peaks 8–11 weeks.
  • Resolution: 50% resolve by 14 weeks; 90% by 20 weeks.
  • Hyperemesis gravidarum (HG): Severe, persistent vomiting → weight loss >5%, ketonuria, electrolyte imbalance. Affects 0.3–3%. Requires aggressive treatment.

Pathophysiology

  • hCG: Peaks 8–11 wks; cross-reacts with TSH receptor → transient hyperthyroidism; correlates with severity.
  • Estrogen/progesterone: Delay gastric emptying, relax LES, enhance olfactory sensitivity.
  • Genetic: GDF15, IGFBP7 (placental hormones) → brainstem nausea centers; high heritability.
  • H. pylori: Associated with HG.

Stepwise Management (ACOG Algorithm)

  1. Lifestyle: Small frequent meals, protein-rich, avoid triggers, ginger (250 mg qid), B6 (pyridoxine 10–25 mg q6–8h).
  2. First-line pharmacologic: Doxylamine 10 mg + B6 10 mg (Diclegis/Bonjesta) — FDA Category A, safe.
  3. Second-line: Ondansetron 4–8 mg q8h (caution: QT prolongation, constipation); metoclopramide, promethazine.
  4. Third-line: Corticosteroids (methylprednisolone 16 mg taper) for refractory HG after 10 wks.
  5. IV fluids, thiamine, electrolyte repletion for HG admission.

Red Flags

  • Inability to tolerate liquids 24 hrs, ketonuria, weight loss >5%, tachycardia, confusion.
  • Onset >10 wks or recurrence after resolution → evaluate for molar pregnancy, multiple gestation, thyroid, GI pathology.

Early intervention prevents escalation; validate patient suffering—NVP is not “just morning sickness.”

Pregnancy & Health - Related Articles